The key for successful uterine fibroid embolization in outpatient setting is good management of pain and other postembolization symptoms. Although several different protocols with different medication regimens have been used successfully in multiple institutions, it is still a challenge for interventional radiologists who should be prepared to provide detailed follow-up plans, continuous staff availability, and an oral medication regimen sufficient to alleviate these symptoms. Moreover, the interventional radiologist should be able to educate the patient about this postprocedural pain and available treatments. 
Introduction
Uterine fibroid embolization (UFE) is an effective treatment for symptomatic uterine fibroid and an alternative to traditional surgical therapies. It successfully controls symptoms in 85%-95% of patients for a median of 24 months. [1] [2] [3] [4] It was recognized and listed by the American College of Obstetricians and Gynecologists in the Level A treatment category in the management of uterine fibroids as a safe and effective treatment option based on long-and short-term outcomes. [5] UFE is accomplished with bilateral occlusion of the uterine artery, with the end point being stasis or near stasis in the artery and with no large uterine artery branches remaining patent. As the fibroid tissue is more vulnerable to embolization than the myometrium, UFE will result in irreversible ischemia and complete infarction of fibroids with gradual reversible ischemia of myometrium. [6, 7] These myometrial ischemic changes most likely cause significant pelvic pain with variable degrees of intensity within the first 24 h. Although such pain should not be considered a complication of UFE but an expected aspect of recovery, [6] it continues to be a challenge for interventional radiologists to treat especially in outpatient setting of UFE as it is the most common reason for readmission. [8] Pain after Uterine
Fibroid Embolization
Post-UFE pain is both variable and unpredictable. It is most commonly described as menstrual-type cramps within the first 24 h after the procedure. Although there is little or no pain during the procedure, the pain starts when embolization is completed. It peaks at 7 h after the procedure and it starts to improve gradually over time. [9] Its intensity is variable and ranges from mild cramps to cramps comparable with childbirth. [10] Interpatient variations occur, [11] and pain degree and experience are unpredictable in general as they are unrelated to the patient age, fibroid size and location, uterine size, and has no significant association with the size of embolic material used. [9, 12] However, the use of a large volume of embolic agents is associated with severe post-UFE pain, [13] while limited or incomplete embolization with polyvinyl alcohol particles or gelatin-coated tris-acryl polymer microspheres may produce significant effective infarction of fibroids with less severe pain. [14] Racial difference in pain perception levels has been noted as a sole predictive factor prior to UFE as Black women recorded greater pain than White women. [9, 15] However, White women who had a greater
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Pain and other postembolization symptom management is the clinical challenge to perform UFE as an outpatient procedure. [16] It is the responsibility of the interventional radiologist to manage the symptoms experienced by these patients immediately after embolization.
McGill University Health Center Protocol
At our institution, McGill University Health Center, we use a simplified protocol for pain management after UFE [ Table 1 ]. The protocol was designed and assessed in close cooperation with the departments of anesthesiology and gynecology. It includes acetaminophen, codeine, and nonsteroidal anti-inflammatory drugs naproxen in addition to mepiridine and fentanyl, when necessary. Based on a previous study by Pisco et al [17] , we started medications the night before and the day of the procedure to reduce the severity of postembolization symptoms, especially in regards to pain. After the procedure, the patient is transferred to the recovery room and aggressive treatment of pain is started until achieving the desired level of pain control. Pain is assessed on a regular basis to enable the administration of analgesics before progression to a level where pain control is virtually impossible. Switching to oral medication starts usually after 4 h. We believe that oral medication if works in hospital, will work at home. The patient will be discharged home after 6-8 h and given appropriate instructions. In general, patients are recommended to take 1 week off from work. All patients are given appropriate contact numbers for the interventional radiology service, should any problems arise, and informed to return to the emergency department in case of severe pelvic pain which is unresponsive to the treatment. Patient follow-up consists of initial telephone contact during the first few days after UFE and a clinic visit at a 3-to 4-month interval. A magnetic resonance imaging scan is obtained at the 3-month follow-up visit. Nearly 81% of patients are discharged on the day of procedure and 19% of patients are admitted for pain control and/or fever control. [16] 
Reported Protocols
Although a fixed pain medication protocol cannot be recommended, [15] several different protocols with different medication regimens have been published in the literatures. [18] [19] [20] [21] [22] They have been used attempting to control the pain and manage the nausea and vomiting associated with UFE in outpatient setting. No consensus regarding the best pain management method after UFE has been achieved, [23] and most of the protocols use a combination of opioid analgesics and nonsteroidal anti-inflammatory drugs to control post-UFE pain in addition to antiemetics for the associated nausea.
In addition, the use of superior hypogastric nerve block may significantly reduce pain and the need for narcotics. [24] The reported medication protocols in outpatient UFE are summarized in Table 2 .
Patient Education
Most UFE patients are otherwise well and are able to communicate their experience and needs regarding pain and other symptoms. To achieve such needs, it is important to inform the patients during the initial consultation and on the morning of the procedure about the expected symptoms during the post-UFE recovery period and the medication regimen that will be used to manage these symptoms, especially the pain and vomiting. Moreover, the patient must receive a written form about all these symptoms with clear instructions regarding the adjustment in their medications, especially those prescribed for pain.
In summary, post-UFE pain in outpatient setting poses unique challenges to the interventional radiologists, who must be fully knowledgeable of the available methods and medications to provide safe and reliable pain relief, tailored for each individual patient. Both the education of patients regarding expected symptoms and the interventionalists' experience with a spectrum of medications in each [22] Before UFE 98% discharged within 8 h Ibuprofen replaces ketorolac after day 3 Klein and Schwartz, 2001 [20] Promethazine suppository 83% of patients were discharged after an average of 6.9 h [24] Regimen split into regimen A and regimen B; after being reviewed by the pain management practice. Regimen B pointed out a possible better solution for managing pain and nausea Superior hypogastric nerve block was used All patients discharged within 6 h Regimen A Before and during UFE Indomethacin Lorazepam 2 mg sublingually 15 min before Fentanyl 50 g IV as needed at 30-min intervals during After UFE Fentanyl 25 g IV as needed at 10-min intervals Metoclopramide 10 mg IV Dexamethasone IV 8 mg [19] Before UFE Morphine was used through a controlled analgesic pump
Most of patients discharged 6-10 h after UFE IV two-thirds 5% dextrose, one-third 0. 
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There are no conflicts of interest. [25] Before UFE Diclofenac 100 mg rectal suppository before UAE Morphine 2-5 mg IV Midazolam 1-2 mg IV Cefazolin 1 g IV After UFE
Long-acting morphine 30 mg orally Morphine 2 mg IV as needed at hourly intervals Demerol 25-75 mg IV as needed Dexamethasone 8 mg IV Dimenhydrinate 50 mg IV Metoclopramide 10-20 mg IV as needed for nausea Prochlorperazine 10 mg rectal suppository At discharge Long-acting morphine 30 mg orally as needed every 12 h for 7 days Morphine 10 mg orally every 4 h as needed for 4 days Metoclopramide 10 mg as needed orally every 8 h for 7 days Diclofenac 100 mg rectal suppository daily for 7 days Ciprofloxacin 500 mg orally daily for 7 days Spencer et al., 2013 [26] Before and during UAE Toradol 10 mg IM/IV 1 h before Zofran 4 mg IV 30 min before Dilaudid 0.5 mg IV 30 min before PCA is started 0.2 mg q10 min without bolus After UFE Toradol 10 mg IV q6 h until AM Zofran 4 mg IV/PO q4 h PRN Dilaudid PCA 0.2 mg q10 min without bolus Colace ® 100 mg PO daily At discharge Percocet 5/325 mg 1-2 tab q4-6 h PRN or Vicodin 5/500 mg 1-2 tab q6 h PRN Naprosyn 500 mg PO BID 7 d then PRN Colace 100 mg daily Miralax 17 g daily PCA: Patient-controlled analgesia
